Literature DB >> 31548812

Exploring reasons for overuse of contralateral prophylactic mastectomy in Canada.

J E Squires1,2, S N Simard3, S Asad2, D Stacey1,2, I D Graham2,4, M Coughlin2, M Clemons5,6,7, J M Grimshaw2,5, J Zhang8, J M Caudrelier9, A Arnaout7,10.   

Abstract

Background: Contralateral prophylactic mastectomy (cpm) in women with known unilateral breast cancer (bca) has been increasing despite the lack of supportive evidence. The purpose of the present study was to identify the determinants of cpm in women with unilateral bca.
Methods: This qualitative descriptive study used semi-structured interviews informed by the Theoretical Domains Framework. We interviewed 74 key informants (surgical oncologists, plastic surgeons, medical oncologists, radiation oncologists, nurses, women with bca) across Canada. Interviews were analyzed using thematic analysis and an analysis for shared and discipline-specific beliefs.
Results: In total, 58 factors influencing the use of cpm were identified: 26 factors shared by various health care professional groups, 15 discipline-specific factors (identified by a single health care professional group), and 17 factors shared by women with unilateral bca. Health care professionals identified more factors discouraging the use of cpm (n = 26) than encouraging its use (n = 15); women with bca identified more factors encouraging use of cpm (n = 12) than discouraging its use (n = 5). The factor most commonly identified by health care professionals that encouraged cpm was lack of awareness of existing evidence or guidelines for the appropriate use of cpm (n = 44, 75%). For women with bca, the factor most likely influencing their decision for cpm was wanting a better esthetic outcome (n = 14, 93%). Conclusions: Multiple factors discouraging and encouraging the use of cpm in unilateral bca were identified. Those factors identify potential individual, team, organization, and system targets for behaviour change interventions to reduce cpm.

Entities:  

Keywords:  Contralateral prophylactic mastectomy; behaviour change; breast cancer; implementation; knowledge translation

Year:  2019        PMID: 31548812      PMCID: PMC6726273          DOI: 10.3747/co.26.4951

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  32 in total

1.  Prophylactic mastectomy of the contralateral breast.

Authors:  Monica Morrow
Journal:  Breast       Date:  2011-10       Impact factor: 4.380

2.  Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy.

Authors:  Ann M Geiger; Carmen N West; Larissa Nekhlyudov; Lisa J Herrinton; In-Liu A Liu; Andrea Altschuler; Sharon J Rolnick; Emily L Harris; Sarah M Greene; Joann G Elmore; Karen M Emmons; Suzanne W Fletcher
Journal:  J Clin Oncol       Date:  2006-03-20       Impact factor: 44.544

3.  Society of Surgical Oncology: position statement on prophylactic mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007.

Authors:  Armando E Giuliano; Susan Boolbol; Amy Degnim; Henry Kuerer; A Marilyn Leitch; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2007-06-28       Impact factor: 5.344

Review 4.  Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis.

Authors:  Oluwadamilola Motunaryo Fayanju; Carolyn R T Stoll; Susan Fowler; Graham A Colditz; Julie A Margenthaler
Journal:  Ann Surg       Date:  2014-12       Impact factor: 12.969

Review 5.  Current knowledge on contralateral prophylactic mastectomy among women with sporadic breast cancer.

Authors:  Abenaa M Brewster; Patricia A Parker
Journal:  Oncologist       Date:  2011-06-14

6.  Changing surgical trends in young patients with early stage breast cancer, 2003 to 2010: a report from the National Cancer Data Base.

Authors:  Catherine E Pesce; Erik Liederbach; Tomasz Czechura; David J Winchester; Katharine Yao
Journal:  J Am Coll Surg       Date:  2014-04-01       Impact factor: 6.113

7.  Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007.

Authors:  Katharine Yao; Andrew K Stewart; David J Winchester; David P Winchester
Journal:  Ann Surg Oncol       Date:  2010-05-12       Impact factor: 5.344

8.  Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment.

Authors:  Todd M Tuttle; Elizabeth B Habermann; Erin H Grund; Todd J Morris; Beth A Virnig
Journal:  J Clin Oncol       Date:  2007-10-22       Impact factor: 44.544

9.  Decision making and factors influencing long-term satisfaction with prophylactic mastectomy in women with breast cancer.

Authors:  Atilla Soran; Ahmad Ibrahim; Malak Kanbour; Kandace McGuire; Fatih L Balci; Ayfer K Polat; Christine Thomas; Marguerite Bonaventura; Gretchen Ahrendt; Ronald Johnson
Journal:  Am J Clin Oncol       Date:  2015-04       Impact factor: 2.339

10.  Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks.

Authors:  Judy C Boughey; Deanna J Attai; Steven L Chen; Hiram S Cody; Jill R Dietz; Sheldon M Feldman; Caprice C Greenberg; Rena B Kass; Jeffrey Landercasper; Valerie Lemaine; Fiona MacNeill; David H Song; Alicia C Staley; Lee G Wilke; Shawna C Willey; Katharine A Yao; Julie A Margenthaler
Journal:  Ann Surg Oncol       Date:  2016-07-28       Impact factor: 5.344

View more
  3 in total

1.  Longitudinal Study of Psychosocial Outcomes Following Surgery in Women with Unilateral Nonhereditary Breast Cancer.

Authors:  David W Lim; Helene Retrouvey; Isabel Kerrebijn; Kate Butler; Anne C O'Neill; Tulin D Cil; Toni Zhong; Stefan O P Hofer; David R McCready; Kelly A Metcalfe
Journal:  Ann Surg Oncol       Date:  2021-04-05       Impact factor: 5.344

2.  Canada follows the US in the rise of bilateral mastectomies for unilateral breast cancer: a 23-year population cohort study.

Authors:  L Findlay-Shirras; I Lima; G Smith; M Clemons; A Arnaout
Journal:  Breast Cancer Res Treat       Date:  2020-10-30       Impact factor: 4.872

Review 3.  Using theories and frameworks to understand how to reduce low-value healthcare: a scoping review.

Authors:  Gillian Parker; Nida Shahid; Tim Rappon; Monika Kastner; Karen Born; Whitney Berta
Journal:  Implement Sci       Date:  2022-01-20       Impact factor: 7.327

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.